+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Teva Pharmaceutical Industries Ltd. - logo

Teva Pharmaceuticals develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. The company has a portfolio of more than 1,000 molecules, producing approximately 64 billion tablets and capsules a year at 66 manufacturing facilities. It currently ranks among the 10 top pharmaceutical companies in the world and is active in 60 countries. Founded in 1901, and based in Israel, Teva employs approximately 58,000 people around the world.

Biosimilars - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Biosimilars - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 116 Pages
  • Global
From
Chronic Myelogenous Leukemia Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Chronic Myelogenous Leukemia Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 186 Pages
  • Global
From
Oncology Biosimilars Market Report 2025 - Product Thumbnail Image

Oncology Biosimilars Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Biosimilar Hormones Market Report 2025 - Product Thumbnail Image

Biosimilar Hormones Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Biosimilar Interleukins Market Report 2025 - Product Thumbnail Image

Biosimilar Interleukins Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Biosimilar Therapeutic Peptides Market Report 2025 - Product Thumbnail Image

Biosimilar Therapeutic Peptides Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Primary Biliary Cholangitis Therapeutics Market - Global Strategic Business Report - Product Thumbnail Image

Primary Biliary Cholangitis Therapeutics Market - Global Strategic Business Report

  • Report
  • February 2026
  • 273 Pages
  • Global
From
Nephrology Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Nephrology Drugs Market - Global Strategic Business Report

  • Report
  • February 2026
  • 386 Pages
  • Global
From
Chronic Kidney Disease (CKD) Drugs - Global Strategic Business Report - Product Thumbnail Image

Chronic Kidney Disease (CKD) Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 179 Pages
  • Global
From
Erythropoietin Drugs - Global Strategic Business Report - Product Thumbnail Image

Erythropoietin Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 179 Pages
  • Global
From
Focal Segmental Glomerulosclerosis - Global Strategic Business Report - Product Thumbnail Image

Focal Segmental Glomerulosclerosis - Global Strategic Business Report

  • Report
  • February 2026
  • 194 Pages
  • Global
From
Lung Cancer Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Lung Cancer Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 110 Pages
  • Global
From
Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type (Immunotherapy, Chemotherapy, and Targeted Therapy), By Route of Administration, By Distribution Channel, By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type (Immunotherapy, Chemotherapy, and Targeted Therapy), By Route of Administration, By Distribution Channel, By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • November 2022
  • 206 Pages
  • Global
From
Multiple Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Multiple Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • January 2023
  • 1452 Pages
  • Global
From
Huntington Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Huntington Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • February 2023
  • 158 Pages
  • Global
From
Parkinson's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Parkinson's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • February 2023
  • 1359 Pages
  • Global
From
Postherpetic Neuralgia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Postherpetic Neuralgia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • February 2023
  • 307 Pages
  • Global
From
Anesthetics Market Report 2025 - Product Thumbnail Image

Anesthetics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Non-Hodgkin Lymphoma (NHL) Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Non-Hodgkin Lymphoma (NHL) Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • November 2025
  • 180 Pages
  • Global
From
Cladribine Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Cladribine Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
Loading Indicator